标题
Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease
作者
关键词
-
出版物
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 37, Issue 7, Pages 720-729
出版商
Wiley
发表日期
2013-02-27
DOI
10.1111/apt.12255
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- NAFLD in the Absence of Metabolic Syndrome: Different Epidemiology, Pathogenetic Mechanisms, Risk Factors for Disease Progression?
- (2012) Yusuf Yilmaz SEMINARS IN LIVER DISEASE
- Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome
- (2011) Yusuf Yilmaz et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- A case–control histological study on the effects of phlebotomy in patients with chronic hepatitis C
- (2011) Massimo Sartori et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States
- (2011) Michael R. Charlton et al. GASTROENTEROLOGY
- Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial
- (2011) Claudia O. Zein et al. HEPATOLOGY
- Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease
- (2011) Kris V. Kowdley et al. HEPATOLOGY
- Endpoints and clinical trial design for nonalcoholic steatohepatitis
- (2011) Arun J. Sanyal et al. HEPATOLOGY
- Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease
- (2010) James E. Nelson et al. HEPATOLOGY
- Patients with Chronic Hepatitis C May be More Sensitive to Iron Hepatotoxicity than Patients with HFE-Hemochromatosis
- (2010) Hisao Hayashi et al. INTERNAL MEDICINE
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling--a propensity score-adjusted observational study
- (2010) L. Valenti et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Lifestyle Modification as the Primary Treatment of NASH
- (2009) Brent A. Neuschwander-Tetri Clinics in Liver Disease
- HFE Genotype, Parenchymal Iron Accumulation, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2009) Luca Valenti et al. GASTROENTEROLOGY
- Haemoglobin and non-alcoholic fatty liver disease: further evidence from a population-based study
- (2009) L. Xu et al. GUT
- Iron Overload: Consequences, Assessment, and Monitoring
- (2009) Ali T. Taher et al. HEMOGLOBIN
- Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
- (2009) Kittichai Promrat et al. HEPATOLOGY
- Decreased survival of subjects with elevated liver function tests during a 28-year follow-up
- (2009) Cecilia Söderberg et al. HEPATOLOGY
- Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease
- (2009) Vincent Wai-Sun Wong et al. HEPATOLOGY
- Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study
- (2008) Winston Dunn et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis
- (2008) M. J. Wood et al. BLOOD
- Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells
- (2008) Richard G. Ruddell et al. HEPATOLOGY
- Hyperferritinemia Is Associated with Insulin Resistance and Fatty Liver in Patients without Iron Overload
- (2008) Robert Brudevold et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started